Article Sidebar
Published:
Jan 30, 2024Keywords:
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors Retain Copyright
Authors retain the copyright of the manuscript they have published in the Journal of the Pan African Thoracic Society. The Authors grant Scientific Scholar an exclusive license to publish the article and the article is made available under the terms of a Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0).
Open Access Publication and Creative Commons Licensing
Journal of the Pan African Thoracic Society is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Compliance with Funder-Mandated Open Access Policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License is able to meet that requirement through the available open-access license for approved funders.
Main Article Content
Point-of-care lactate as a predictor of 7-day morbidity and mortality in critically ill patients presenting to the emergency department in Kenyatta National Hospital
Abstract
Objectives: Hyperlactatemia is associated with increased risk of mortality. Point-of-care (POC) lactate levels have been used worldwide in the emergency department (ED) and critical care units for risk stratification. The aim of this study was to determine whether POC lactate levels are predictive of outcomes in our low-resource setting.
Materials and Methods: This was a non-interventional prospective cohort study carried out at the ED Critical Care wards in Kenyatta National Hospital between June 12, 2021, and July 25, 2021. The study included consecutively consenting adults above 18 years at the ED who were critically ill as indicated by a Modified Early Warning Score of equal to or above 5. Lactate was measured using a handheld Statstrip lactate meter. Patients were followed up for 7 days, and outcomes were documented.
Results: Two hundred and eighty-one patients were enrolled in the study. The mean lactate level was 4.0 mmoL/L with a median interquartile range of 3.0. Hyperlactatemia was evident in 161 (57%) using a cutoff of 2.5 mmoL/L. The all-cause mortality rate was 33.8%. Type A hyperlactatemia was the most common at 84.3% and 17.7% in Type B. Type A hyperlactatemia mortality rate was 37.1% and Type B 15.9% (odds ratio [OR]: 3.1, 95% confidence interval [CI]: 1.3– 7.3, P = 0.006). In the high lactate group, the 7-day mortality rate was 42.2% compared to a mortality rate of 22.5% in the normal lactate group (OR: 2.5, 95% CI: 1.5–4.3, P = 0.001). Hyperlactatemia was associated with an increased need for intensive care unit admission (OR: 2.2, 95% CI: 1.3–3.7, P = 0.002) and organ support mainly mechanical ventilation (OR: 2.6, 95% CI: 1.5–4.4, P = 0.001) and inotropic/vasopressors support (OR: 2.7, 95% CI: 1.2–6.2, P = 0.016).
Conclusion: POC lactate is an independent predictor of 7-day mortality with a 2-a fold increased risk of mortality and was associated with increased need for organ support.
